| P2093 | author name string | K B Horwitz | |
| P2860 | cites work | Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA | Q24299325 |
| | Sequence and expression of human estrogen receptor complementary DNA | Q24299678 |
| | Genomic organization of the human oestrogen receptor gene | Q24564158 |
| | Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism | Q69366751 |
| | Genomic DNA analysis of the estrogen receptor gene in breast cancer | Q69377616 |
| | Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy | Q69397268 |
| | Tissue-specific regulation of rat estrogen receptor mRNAs | Q69617471 |
| | Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines | Q69636971 |
| | Chemoprevention for breast cancer: are we ready? | Q70120449 |
| | Is a functional estrogen receptor always required for progesterone receptor induction in breast cancer? | Q71100427 |
| | Characterization of estrogen receptor variant mRNAs from human breast cancers | Q28262735 |
| | Evidence for a previously unidentified upstream exon in the human oestrogen receptor gene | Q28273041 |
| | Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A | Q29619449 |
| | Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. | Q33880351 |
| | Truncated forms of DNA-binding estrogen receptors in human breast cancer | Q34194960 |
| | Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture | Q34219324 |
| | Establishment and characterization of a cell line of human breast carcinoma origin | Q34294071 |
| | T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance. | Q34979932 |
| | Cloning of the chicken progesterone receptor | Q35050960 |
| | Molecular cloning of the chicken progesterone receptor | Q35051358 |
| | The Molecular Biology of RU486. Is There a Role for Antiprogestins in the Treatment of Breast Cancer?* | Q36266619 |
| | Estrogen receptor variants in human breast cancer | Q37796937 |
| | Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. | Q38319428 |
| | Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer. | Q38334441 |
| | Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor | Q38341530 |
| | Steroid hormone antagonists at the receptor level: a role for the heat-shock protein MW 90,000 (hsp 90). | Q39690695 |
| | Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis | Q39945174 |
| | An assessment of current achievements in the systemic management of breast cancer | Q40181973 |
| | Tamoxifen-induced tumor stimulation and withdrawal response | Q40285008 |
| | Identification of a variant form of the human estrogen receptor with an amino acid replacement | Q40538303 |
| | PvuII RFLP inside the human estrogen receptor gene | Q40564888 |
| | A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors | Q41274369 |
| | Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry | Q41640879 |
| | A single nucleotide substitution in the D domain of estrogen receptor cDNA causes amino acid alteration from Glu-279 to Lys-279 in a murine transformed leydig cell line (B-1 F) | Q41677862 |
| | Mechanisms involved in the evolution of progestin resistance in human breast cancer cells | Q41687697 |
| | Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells | Q42481485 |
| | Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens | Q42523366 |
| | Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells | Q43411264 |
| | Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues | Q43656969 |
| | The N-terminal region of the chicken progesterone receptor specifies target gene activation | Q43762001 |
| | Resistance to endocrine therapy. A panel discussion | Q44224117 |
| | Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer | Q44524956 |
| | Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line | Q44638074 |
| | Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain | Q46401096 |
| | Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. | Q54286500 |
| | Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens. | Q54347791 |
| | Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration | Q54376589 |
| | A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. | Q54378273 |
| | Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. | Q54519992 |
| | Receptors bound to antiprogestin form abortive complexes with hormone responsive elements | Q59081172 |
| | Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor | Q67294717 |
| | Steroid receptor analyses of nine human breast cancer cell lines | Q67351998 |
| | The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer | Q67927526 |
| | Variant human breast tumor estrogen receptor with constitutive transcriptional activity | Q68183370 |
| | Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats | Q68718298 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 119-130 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Mechanisms of hormone resistance in breast cancer | |
| P478 | volume | 26 | |